Okomera
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9 b Rue D'alembert, Paris, Ile-de-France...Website
www.okomera.comRevenue
<$5 MillionIndustry
About Okomera
Is Okomera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Okomera is spiking on competitors!
Product Launch: Get notified when Okomera launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Okomera recently announced quarterly report
Click to see if Okomera had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Okomera
Okomera, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Okomera has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Okomera has new funding data
Recommended Actions
Find VP level buyers at Okomera
Find 3 more new buyers
Company Profile Activity
Activity Insights
Okomera is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Okomera is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Okomera.
Okomera financials insights
Gather financial insights about Okomera, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Grant
$1.6M
Okomera Tech Stack
A closer look at the technologies used by Okomera
Most Recent Scoops
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Okomera
We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity.... Read More